0
0
London, January 16, 2025—The UK government has officially banned the use of the so-called “zombie drug” xylazine, a high-strength animal sedative known for its devastating effects on users, as part of its ongoing efforts to tackle drug-related deaths and dismantle criminal drug networks.
Effective Wednesday, the ban categorizes xylazine under Class C of the Misuse of Drugs Act, with unlawful possession punishable by up to two years in prison, and supply carrying a maximum sentence of 14 years. The move follows the government’s September announcement to prohibit xylazine along with 21 other dangerous substances, including highly potent synthetic opioids like nitazenes.
Xylazine, also referred to as “tranq,” is notorious for its impact on long-term users, leaving them in a trance-like state and causing severe non-healing skin lesions. While primarily intended as an animal tranquilizer, the drug has increasingly been mixed with opioids such as heroin and even found in cannabis vapes, according to the UK Home Office.
Rising Concern Over Drug-Related Deaths
The UK has seen a surge in drug-related fatalities, with nitazenes alone contributing to at least 400 deaths since June 2023. Researchers from King’s College London have flagged xylazine as being “widespread” in the illicit drug market, exacerbating the already critical issue of substance misuse.
Policing Minister Diana Johnson underscored the government’s commitment to tackling the crisis. “We are dedicated to driving down drug misuse and harms through prevention and treatment while acting quickly to stop the criminals peddling these harmful substances,” she said.
Global Implications
The UK is not alone in grappling with the xylazine crisis. The United States has reported a sharp rise in overdose deaths involving the drug, with a staggering 30-fold increase between 2018 and 2021. This alarming trend has raised concerns among public health experts about the global spread of such substances.
Strengthening Drug Laws
The latest ban is part of the UK’s broader strategy to curb drug misuse and minimize harm. The Misuse of Drugs Act categorizes controlled substances into three classes, with Class A drugs posing the highest risks and carrying the most severe penalties. While xylazine is categorized as Class C, its lethal potential when combined with other drugs underscores the urgency of this legislative action.
The government’s firm stance reflects its resolve to protect vulnerable communities and disrupt the operations of criminal gangs exploiting the drug trade. As law enforcement and health agencies work together to address this crisis, the ban on xylazine marks a critical step in safeguarding public health.
